Taiwan FDA registration 5765e1088df17e953a41a599c2e2dee1
Rebauls bone replacement
TW: 瑞保斯骨替代物
Taiwan·Risk Class 2·ORTHOREBIRTH CO., Ltd.;; Kaigen Pharma Co., Ltd. Tenjin Factory·Registered Feb 14, 2020 – Feb 14, 2030ActiveRegistration details
- Analysis ID
- 5765e1088df17e953a41a599c2e2dee1
- Customs Code
- DHA05603319501
Company information
- Manufacturer Country
- Japan
- Authorized Representative
- HOLLING BIO-PHARMA. CORP.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- N Orthopedics
- Product Type (Level 2)
- N.3045 Absorbable Calcium Salt Bone Cavity Filling Device
- Import Information
- Contract manufacturing;; input
Dates and status
- Registration Date
- Feb 14, 2020
- Expiry Date
- Feb 14, 2030
About this record
Access comprehensive regulatory information for Rebauls bone replacement in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5765e1088df17e953a41a599c2e2dee1 and manufactured by ORTHOREBIRTH CO., Ltd.;; Kaigen Pharma Co., Ltd. Tenjin Factory. The authorized representative in Taiwan is HOLLING BIO-PHARMA. CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices